ABVC BioPharma Profit Margin

ABVC BioPharma (ABVC) currently reports a profit margin of -40.67% as of March 2026. That compares with -3.56% in the prior-year period — up 88.6% year over year. That is below the Industrials sector average of 10.05%. Use the charts on this page to explore ABVC BioPharma's profit margin history and peer comparisons.

ABVC BioPharma's profit margin increased from -3.56% to -40.67% — a 88.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ABVC BioPharma's profit margin of -40.67% is lower than the Industrials sector average of 10.05%. That is roughly 504.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but ABVC BioPharma's current -40.67% should be judged against Industrials norms (sector average: 10.05%) and against ABVC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -40.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 10.05%. From there, open related valuation or income-statement pages for ABVC BioPharma, and consider following ABVC for alerts when major investors trade the stock.